FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

769000008: Subcutaneous dose form (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3687767011 Subcutaneous dose form en Synonym Active Entire term case insensitive SNOMED CT core module
3687768018 Subcutaneous dose form (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Subcutaneous dose form Is a Pharmaceutical dose form false Inferred relationship Existential restriction modifier
Subcutaneous dose form Has dose form intended site Subcutaneous true Inferred relationship Existential restriction modifier
Subcutaneous dose form Is a Parenteral dose form true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing testosterone in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Prolonged-release subcutaneous implant Is a True Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing etonogestrel in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing levonorgestrel in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing only etonogestrel in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing only testosterone in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing goserelin in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing only goserelin in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing only levonorgestrel in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing estradiol in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing only estradiol in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing afamelanotide in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing only afamelanotide in subcutaneous dose form (medicinal product form) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing precisely testosterone 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing precisely testosterone 200 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing precisely testosterone 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing precisely estradiol 25 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing precisely estradiol 50 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing precisely testosterone 200 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing precisely estradiol 100 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) Has manufactured dose form False Subcutaneous dose form Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start